Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OraSure Preps October Launch Of First-Ever In-Home HIV Test

This article was originally published in The Gray Sheet

Executive Summary

Firm gains PMA approval for OraQuick July 3, making it the first available HIV test that can be performed entirely in the home by untrained users.


Related Content

OTC Tests For Flu, Strep, STIs Up For Discussion At FDA Panel Meeting
FDA Panel To Ponder Approval Factors For OTC Infectious Disease Diagnostics
New Products In Brief
News In Brief
OraSure In-Home HIV Test’s Promise Outweighs Risks, Panel Concludes


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts